ATC Group: L04AD Calcineurin inhibitors

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L04AD in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L04 Immunosuppressants
3 L04A Immunosuppressants
4 L04AD Calcineurin inhibitors

Group L04AD contents

Code Title
L04AD01 Ciclosporin
L04AD02 Tacrolimus
L04AD03

Active ingredients in L04AD

Active Ingredient

Ciclosporin (also known as ciclosporin A) is a cyclic polypeptide immunomodulator with immunosuppressant properties. It has been shown to prolong survival of allogeneic transplants in animals and significantly improved graft survival in all types of solid organ transplantation in man. Ciclosporin has also been shown to have an anti-inflammatory effect.

Tacrolimus is a highly potent immunosuppressive agent. In particular, tacrolimus inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection. Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor.

Voclosporin is a calcineurin-inhibitor immunosuppressant that inhibits calcineurin in a dose-dependent manner. The immunosuppressant activity results in inhibition of lymphocyte proliferation, T-cell cytokine production, and expression of T-cell activation surface antigens.

Related product monographs

Document Type Information Source  
 ADOPORT Capsule, hard MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DAILIPORT Prolonged-release hard capsule MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DEXIMUNE Capsule, soft MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 LUPKYNIS Soft capsule MPI, EU: SmPC European Medicines Agency (EU)
 MODIGRAF Granules for oral suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 NEORAL Oral solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 PROGRAF Concentrate for solution for infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 PROGRAF Hard capsule MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 RESTASIS Emulsion MPI, US: SPL/PLR FDA, National Drug Code (US)
 SANDIMMUN Concentrate for solution for infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 SANDIMMUNE Capsule, Oral solution, Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)
 TACFORIUS Prolonged-release hard capsule MPI, EU: SmPC Health Products Regulatory Authority (IE)